Literature DB >> 33274386

Targeting Soluble DPP-4 for Insulin Resistance: Origin Matters.

Lale Ozcan1, Devram S Ghorpade2, Ira Tabas1,3,4.   

Abstract

Entities:  

Keywords:  DPP-4; insulin resistance; obesity; type 2 diabetes

Mesh：

Substances：

Year:  2021        PMID： 33274386      PMCID： PMC7947836          DOI： 10.1210/clinem/dgaa902

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.

Authors:  Elodie M Varin; Erin E Mulvihill; Jacqueline L Beaudry; Gemma Pujadas; Shai Fuchs; Jean-François Tanti; Sofia Fazio; Kirandeep Kaur; Xiemin Cao; Laurie L Baggio; Dianne Matthews; Jonathan E Campbell; Daniel J Drucker
Journal:  Cell Metab       Date:  2018-11-01       Impact factor: 27.287

2.  Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.

Authors:  Erin E Mulvihill; Elodie M Varin; Bojana Gladanac; Jonathan E Campbell; John R Ussher; Laurie L Baggio; Bernardo Yusta; Jennifer Ayala; Melissa A Burmeister; Dianne Matthews; K W Annie Bang; Julio E Ayala; Daniel J Drucker
Journal:  Cell Metab       Date:  2016-11-10       Impact factor: 27.287

3.  Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people.

Authors:  Yasushi Kirino; Masako Sei; Kazuyoshi Kawazoe; Kazuo Minakuchi; Youichi Sato
Journal:  Endocr J       Date:  2012-06-23       Impact factor: 2.349

Review 4.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

Authors:  Daniel J Drucker; Michael A Nauck
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

5.  Circulating sDPP-4 is Increased in Obesity and Insulin Resistance but Is Not Related to Systemic Metabolic Inflammation.

Authors:  Nathalie Rohmann; Kristina Schlicht; Corinna Geisler; Tim Hollstein; Carina Knappe; Laura Krause; Stefanie Hagen; Alexia Beckmann; Anna Katharina Seoudy; Perdita Wietzke-Braun; Katharina Hartmann; Dominik Schulte; Kathrin Türk; Jan Beckmann; Witigo von Schönfels; Franziska Anna Hägele; Anja Bosy-Westphal; Andre Franke; Stefan Schreiber; Matthias Laudes
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

6.  Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.

Authors:  Devram S Ghorpade; Lale Ozcan; Ze Zheng; Sarah M Nicoloro; Yuefei Shen; Emily Chen; Matthias Blüher; Michael P Czech; Ira Tabas
Journal:  Nature       Date:  2018-03-21       Impact factor: 49.962

7.  Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.

Authors:  Daniela Lamers; Susanne Famulla; Nina Wronkowitz; Sonja Hartwig; Stefan Lehr; D Margriet Ouwens; Kristin Eckardt; Jean M Kaufman; Mikael Ryden; Stefan Müller; Franz-Georg Hanisch; Johannes Ruige; Peter Arner; Henrike Sell; Juergen Eckel
Journal:  Diabetes       Date:  2011-05-18       Impact factor: 9.461

8.  Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.

Authors:  Laurie L Baggio; Elodie M Varin; Jacqueline A Koehler; Xiemin Cao; Yuliya Lokhnygina; Susanna R Stevens; Rury R Holman; Daniel J Drucker
Journal:  Nat Commun       Date:  2020-07-28       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.